Top

BY Jill Russell, Ph.D.

Immunology research to investigate the mechanisms of a new aerosol treatment, which induces an innate immune response to protect against pathogens that cause pneumonia, asthma, and other lung diseases, has earned major funding from the National Heart, Lung, and Blood Institute.

“This research will help protect patients who are most vulnerable to pneumonia, especially patients with cancer,” said Scott Evans, M.D., the principal...

Pneumonia in the lungs

BY Devon Carter

Over the past decade, immune checkpoint inhibitors have shown success in treating several types of cancer, including melanoma, non-small cell...

BY Clayton Boldt, Ph.D.

MD Anderson Cancer Center and Accelerator Life Science Partners, a leading life science investment and management firm, have launched Magnolia...

Yogini Patel

BY Bryan Tutt

Cancer patients who have undergone lymph node removal or radiation therapy as part of cancer treatment know all too well the pain and discomfort...

BY MD Anderson Staff

A type of functional brain training known as neurofeedback shows promise in reducing symptoms of chemotherapy-induced nerve damage, or neuropathy...

BY Ron Gilmore

The 90 percent of cancer patients who experience pain due to nerve damage caused by tumors, surgery, chemotherapy or radiation may someday...

BY Jill Delsigne

Cancer survivors are more likely to die from heart disease than cancer; therefore, patients must be closely monitored for heart problems during...

BY Laura Sussman

Whole brain radiation to treat cancer that has spread to the brain is associated with significantly worse cognitive function than radiosurgery...

BY Laura Sussman

In a study of women with high-grade uterine cancer, researchers at MD Anderson Cancer Center found sentinel lymph node (SLN) mapping accurately...